Skip to main content
. 2021 Jun 4;8:649252. doi: 10.3389/fvets.2021.649252

Table 3.

Pooled prevalence of Brucella in buffalo worldwide.

No. studies No. tested No. positive % (95% CI*) Heterogeneity Univariate meta-regression
χ2 P-value I2 (%) P-value Coefficient (95% CI)
Region*
Asia 12 26,099 503 3.9% (1.5–7.2) 1,105.92 <0.01 99.0%
North America 3 3,020 362 17.2% (0–78.5) 1,017.03 <0.01 99.8%
South America 3 4,733 225 5.0% (3.7–6.3) 4.08 0.13 51.0%
Europe 4 1,790 622 35.1% (4.8–74.6) 666.23 <0.01 99.5% 0.0002 0.368 (0.176 to 0.560)
Africa 4 1,071 115 11.3% (3.3–22.9) 49.66 <0.01 94.0%
Sampling years
After 2010 16 25,890 685 4.2% (1.8–7.5) 1,395.04 <0.01 98.9%
Before 2010 10 10,487 1,116 20.8% (5.6–42.2) 2,955.04 0 99.7% 0.0026 0.262 (0.091 to 0.433)
Quality level
4–5 10 17,782 999 10.8% (5.5–17.6) 1,317.67 <0.01 99.3% 0.7643 0.027 (−0.148 to 0.201)
2–3 16 18,931 828 9.1% (2.6–18.7) 3,202.11 0 99.5%
0–1 0 0 0 ND ND ND ND ND ND
Method*
RBPT 6 16,010 113 6.5% (2.1–13.0) 409.32 <0.01 98.8%
SAT 6 9,087 497 7.3% (0–25.1) 1,243.59 <0.01 99.6%
ELISA 11 10,432 508 13.5% (8.5–19.4) 544.23 <0.01 98.2%
CFT 2 794 101 27.3% (0.7–70.8) 34.64 <0.01 97.1% 0.0997 0.209 (−0.040 to 0.458)
Reproductive health
Reproductive issues 2 1,607 101 4.8% (3.6–6.0) 0.30 0.58 0.0%
Health 2 2,736 108 4.8% (2.1–8.7) 8.60 <0.01 88.4% 0.5150 −0.039 (−0.157 to 0.079)
Feeding mode
Captive 13 25,833 829 10.6% (4.9–18.1) 2,641.95 0 99.5%
Stock 10 7,857 931 11.5% (3.6–23.0) 1,469.46 <0.01 99.4% 0.8654 0.015 (−0.159 to 0.189)
Farming mode
Intensification 10 15,824 509 8.5% (0.9–22.2) 2,246.06 0.00 99.6%
Artificial 8 12,998 526 10.7% (6.6–15.7) 320.63 <0.01 97.8% 0.5670 0.059 (−0.142 to 0.259)
Environment
Wetland 8 18,016 234 5.1% (1.8–10.4) 678.65 <0.01 99.0%
Dryland 6 3,796 239 6.4% (2.0–12.9) 120.24 <0.01 95.8% 0.7100 0.028 (−0.121 to 0.178)
Sex
Male 2 266 13 4.4% (2.0–7.4) 0.45 0.50 0.0%
Female 3 4,183 214 10.1% (3.4–19.7) 27.63 <0.01 92.8% 0.4600 0.080 (−0.132 to 0.292)
Age of buffalo*
Lactating buffalo 3 2,378 447 26.9% (1.8–66.5) 742.12 <0.01 99.7% 0.2619 0.247 (−0.185 to 0.680)
Juvenile buffalo 2 3,934 181 3.4% (2.8–4.1) 0.37 0.54 0.0%
Adult buffalo 2 477 37 10.8% (1.1–28.0) 14.73 <0.01 93.2%
Income level
High 6 2,224 907 32.8% (7.5–65.2) 1,000.03 <0.01 99.5% <0.0001 0.386 (0.244 to 0.528)
Middle 11 30,300 647 5.0% (2.3–8.6) 1,225.49 <0.01 99.2%
Low 9 4,189 273 5.3% (3.2–7.9) 76.94 <0.01 89.6%
Country
China 3 12,831 2 0.5% (0–1.2) 9.67 <0.01 79.3%
Pakistan 5 2,340 218 4.6% (2.5–7.2) 22.64 <0.01 82.3%
Trinidad 2 434 285 27.8% (0–99.9) 178.75 <0.01 99.4%
Brazil 3 4,733 225 5.0% (3.7–6.3) 4.08 0.13 51.0%
India 3 10,088 326 10.4% (3.9–19.3) 202.04 <0.01 99.0%
Italy 4 1,790 622 35.1% (3.8–74.6) 666.23 <0.01 99.5%
Costa Rica 1 2,586 77 3.0% (3.7–7.6) 0.00 ND* ND
Egypt 2 903 80 4.5% (0–18.5) 27.90 <0.01 96.4%
Zimbabwe 1 106 18 17.0% (10.4–24.8) 0.00 ND ND
Sri Lanka 1 840 35 4.2% (2.9–5.6) 0.00 ND ND
Africa 1 62 17 27.4% (17.0–39.3) 0.00 ND ND
Sample
Serum 25 36,599 1,827 10.3% (5.9–15.8) 4,942.66 0.00 99.5% 0.1798 0.284 (−0.131 to 0.699)
Milk 1 114 0 0% (0–1.5) 0.00 ND* ND*
Wild*
No 2 206 7 2.1% (0–12.9) 9.83 <0.01 89.8%
Yes 2 426 40 11.1% (3.1–22.9) 8.27 <0.01 87.9% 0.1583 0.185 (−0.072 to 0.443)
Total 26 36,713 1,827 9.7% (5.5–14.9) 4,948.43 0.00 99.5%

CI*: Confidence interval.

Region*: Asia: China, Pakistan, India, and Sri Lanka; North America: Trinidad and Costa Rica; South America: Brazil; Europe: Italy; Africa: Egypt, Zimbabwe, and South Africa.

Method*: CFT, Complement fixation test; ELISA, Enzyme-linked immunosorbent assay; RBPT, Rose Bengal plate test; SAT, Serum agglutination test.

Age of buffalo*: Lactating buffalo: >1 year; Juvenile buffalo: 1–3 years; Adult buffalo: >3 years.

Others*: Aborted fetuses and vaginal swabs.

ND*: no data.

Wild*: Contact with wild animals.